Related Experiment Video
Updated: May 13, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Assessing adherence to antiretroviral therapy in randomized HIV clinical trials: a review of currently used methods
Fabienne Marcellin1, Bruno Spire, Maria Patrizia Carrieri
1INSERM, UMR912 (SESSTIM), 13006, Marseille, France. fabienne.marcellin@inserm.fr
Abstract:
Antiretroviral therapy for the treatment of HIV infection requires high levels of adherence to both maintain plasma HIV RNA at undetectable levels and prevent the emergence of drug resistance. As adherence to treatment is a major criterion for the evaluation of therapeutic outcomes, randomized clinical trials (RCTs) conducted among HIV-infected patients commonly include an assessment of adherence. However, there is still no gold-standard tool for assessing adherence behaviors in HIV RCTs. The methods currently used to collect and analyze adherence data are varied, which makes the comparison of results between studies difficult. The scope of this article is to review and discuss the range of adherence measures currently used in RCTs conducted among HIV-infected adults.
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Retrovirus Life Cycles
Measurement of Bioavailability: Pharmacodynamic Methods
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Bioavailability Study Design: Healthy Subjects Versus Patients

